A Single B-Repeat of Staphylococcus epidermidis Accumulation-Associated Protein Induces Protective Immune Responses in an Experimental Biomaterial-Associated Infection Mouse Model

ABSTRACT Nosocomial infections are the fourth leading cause of morbidity and mortality in the United States, resulting in 2 million infections and ∼100,000 deaths each year. More than 60% of these infections are associated with some type of biomedical device. Staphylococcus epidermidis is a commensal bacterium of the human skin and is the most common nosocomial pathogen infecting implanted medical devices, especially those in the cardiovasculature. S. epidermidis antibiotic resistance and biofilm formation on inert surfaces make these infections hard to treat. Accumulation-associated protein (Aap), a cell wall-anchored protein of S. epidermidis, is considered one of the most important proteins involved in the formation of S. epidermidis biofilm. A small recombinant protein vaccine comprising a single B-repeat domain (Brpt1.0) of S. epidermidis RP62A Aap was developed, and the vaccine's efficacy was evaluated in vitro with a biofilm inhibition assay and in vivo in a murine model of biomaterial-associated infection. A high IgG antibody response against S. epidermidis RP62A was detected in the sera of the mice after two subcutaneous immunizations with Brpt1.0 coadministered with Freund's adjuvant. Sera from Brpt1.0-immunized mice inhibited in vitro S. epidermidis RP62A biofilm formation in a dose-dependent pattern. After receiving two immunizations, each mouse was surgically implanted with a porous scaffold disk containing 5 × 106 CFU of S. epidermidis RP62A. Weight changes, inflammatory markers, and histological assay results after challenge with S. epidermidis indicated that the mice immunized with Brpt1.0 exhibited significantly higher resistance to S. epidermidis RP62A implant infection than the control mice. Day 8 postchallenge, there was a significantly lower number of bacteria in scaffold sections and surrounding tissues and a lower residual inflammatory response to the infected scaffold disks for the Brpt1.0-immunized mice than for of the ovalbumin (Ova)-immunized mice.

[1]  Jinan Li,et al.  Protective effects of plasmin(ogen) in a mouse model of Staphylococcus aureus-induced arthritis. , 2008, Arthritis and rheumatism.

[2]  J. Derrick,et al.  The Terminal A Domain of the Fibrillar Accumulation-Associated Protein (Aap) of Staphylococcus epidermidis Mediates Adhesion to Human Corneocytes , 2009, Journal of bacteriology.

[3]  R. Oldinski,et al.  Chitosan-based nanofibrous membranes for antibacterial filter applications. , 2013, Carbohydrate Polymers.

[4]  N. Barekzi,et al.  Efficacy of Locally Delivered Polyclonal Immunoglobulin against Pseudomonas aeruginosa Peritonitis in a Murine Model , 1999, Antimicrobial Agents and Chemotherapy.

[5]  Jeffrey J. Wilson,et al.  Structural basis for Zn2+-dependent intercellular adhesion in staphylococcal biofilms , 2012, Proceedings of the National Academy of Sciences.

[6]  H. Rohde,et al.  Staphylococcus epidermidis Biofilms: Functional Molecules, Relation to Virulence, and Vaccine Potential. , 2009, Topics in current chemistry.

[7]  J. Clarke,et al.  Staphylococcal biofilm-forming protein has a contiguous rod-like structure , 2012, Proceedings of the National Academy of Sciences.

[8]  M. Otto.  Staphylococcus epidermidis — the 'accidental' pathogen , 2009, Nature Reviews Microbiology.

[9]  G. Peters,et al.  A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces , 1997, Infection and immunity.

[10]  E. Lautenbach.  Impact of Changes in Antibiotic Use Practices on Nosocomial Infections and Antimicrobial Resistance – Clostridium Difficile and Vancomycin-resistant Enterococcus ( VRE ) , 2001 .

[11]  Alex Bateman,et al.  The G5 domain: a potential N-acetylglucosamine recognition domain involved in biofilm formation , 2005, Bioinform..

[12]  D. Grainger,et al.  Prophylactic treatment of gram-positive and gram-negative abdominal implant infections using locally delivered polyclonal antibodies. , 2002, Journal of biomedical materials research.

[13]  T. S. Wilkinson,et al.  Staphylococcus epidermidis in Biomaterial-Associated Infections , 2013 .

[14]  R. Feldman,et al.  The influence of antibodies on Staphylococcus epidermidis adherence to polyvinylpyrrolidone-coated silicone elastomer in experimental biomaterial-associated infection in mice. , 2009, Biomaterials.

[15]  J. Costerton,et al.  Bacterial biofilms: a common cause of persistent infections. , 1999, Science.

[16]  H. Rohde,et al.  Induction of Staphylococcus epidermidis biofilm formation via proteolytic processing of the accumulation‐associated protein by staphylococcal and host proteases , 2005, Molecular microbiology.

[17]  B. Stijlemans,et al.  Vaccination with SesC Decreases Staphylococcus epidermidis Biofilm Formation , 2012, Infection and Immunity.

[18]  D. Grainger,et al.  Locally Delivered Polyclonal Antibodies Potentiate Intravenous Antibiotic Efficacy Against Gram-Negative Infections , 2002, Pharmaceutical Research.

[19]  Min Zhang,et al.  Development of a poly(ether urethane) system for the controlled release of two novel anti-biofilm agents based on gallium or zinc and its efficacy to prevent bacterial biofilm formation. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[20]  H. Rohde,et al.  Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. , 2007, Biomaterials.

[21]  K. Horii,et al.  A zinc-dependent adhesion module is responsible for intercellular adhesion in staphylococcal biofilms , 2008, Proceedings of the National Academy of Sciences.

[22]  S. Hammer,et al.  Staphylococcus epidermidis infections. , 1983, Annals of internal medicine.

[23]  V. Vasilevko,et al.  Importance of IgG2c isotype in the immune response to β-amyloid in amyloid precursor protein/transgenic mice , 2003, Neuroscience Letters.

[24]  D. Cardo,et al.  Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002 , 2007, Public health reports.

[25]  R. Gagnon,et al.  Experimental Staphylococcus epidermidis implant infection in the mouse. Kinetics of rifampin and vancomycin action. , 1992, ASAIO journal.

[26]  R. Scott,et al.  The Direct medical costs of healthcare-associated infections in U.S. hospitals and the benefits of prevention , 2009 .

[27]  Roland M. Martin,et al.  The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. , 1998, Journal of immunological methods.

[28]  M. Hosseini,et al.  Slime layer formation and the prevalence of mecA and aap genes in Staphylococcus epidermidis isolates. , 2011, Journal of infection in developing countries.

[29]  D. Qu,et al.  Monoclonal Antibodies against Accumulation-Associated Protein Affect EPS Biosynthesis and Enhance Bacterial Accumulation of Staphylococcus epidermidis , 2011, PloS one.

[30]  张静,et al.  Banana Ovate family protein MaOFP1 and MADS-box protein MuMADS1 antagonistically regulated banana fruit ripening , 2015 .

[31]  G. Rossi,et al.  Comparison of Microbiological, Histological, and Immunomodulatory Parameters in Response to Treatment with Either Combination Therapy with Prednisone and Metronidazole or Probiotic VSL#3 Strains in Dogs with Idiopathic Inflammatory Bowel Disease , 2014, PloS one.

[32]  J. O’Gara,et al.  Staphylococcus epidermidis biofilms: importance and implications. , 2001, Journal of medical microbiology.

[33]  D. Grainger,et al.  Surgical irrigation with pooled human immunoglobulin G to reduce post-operative spinal implant infection. , 2000, Tissue engineering.

[34]  T. van der Poll,et al.  Biomaterial-associated persistence of Staphylococcus epidermidis in pericatheter macrophages. , 2000, The Journal of infectious diseases.

[35]  J. Bryers,et al.  Inhibition of Biofilm Formation by Monoclonal Antibodies against Staphylococcus epidermidis RP62A Accumulation-Associated Protein , 2005, Clinical Diagnostic Laboratory Immunology.

[36]  H. Salter,et al.  Possible allelic structure of IgG2a and IgG2c in mice. , 2012, Molecular immunology.

[37]  Shaoyi Jiang,et al.  Zwitterionic hydrogels implanted in mice resist the foreign-body reaction , 2013, Nature Biotechnology.